Skip to main content
Log in

Pharmacokinetics and Histopathological Findings of Chemoembolization Using Cisplatin Powder Mixed with Degradable Starch Microspheres in a Rabbit Liver Tumor Model

  • Laboratory Investigation
  • Published:
CardioVascular and Interventional Radiology Aims and scope Submit manuscript

Abstract

Purpose

The purpose of this study is to evaluate the pharmacokinetics and histopathological findings of transarterial chemoembolization (TACE) using cisplatin powder mixed with degradable starch microspheres (DSM) (Cis/DSM-TACE) compared with cisplatin arterial infusion (Cis-AI).

Materials and Methods

Eighteen rabbits with VX2 liver tumors were divided into two groups: Cis/DSM-TACE (n = 9) and Cis-AI (n = 9) groups. In the Cis/DSM-TACE group, a mixture of cisplatin powder and DSM was injected until stasis of hepatic arterial flow was achieved. In the Cis-AI group, cisplatin solution was infused.

Results

The platinum concentrations in VX2 tumors in the Cis/DSM-TACE group at 24 and 72 h were significantly elevated compared with those in the Cis-AI group (P = .016 and .019, respectively). There were no significant differences in the platinum concentrations in plasma. Histopathological examination revealed the presence of several microspheres inside the tumors at 1 h, which completely disappeared at 24 h. Tumor cell apoptosis at 1 h in the Cis/DSM-TACE group was more frequently observed compared with that in the Cis-AI group (P = .006).

Conclusions

TACE using cisplatin powder mixed with DSM provides a higher drug concentration in tumors, thereby achieving stronger antitumor effects compared with arterial infusion of cisplatin solution.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Duan F, Wang EQ, Lam MG, et al. Superselective chemoembolization of HCC: comparison of short-term safety and efficacy between drug-eluting LC beads, quadraspheres, and conventional ethiodized oil emulsion. Radiology. 2016;278(2):612–21.

    Article  PubMed  Google Scholar 

  2. Huppert P, Wenzel T, Wietholtz H, et al. Transcatheter arterial chemoembolization (TACE) of colorectal cancer liver metastases by irinotecan-eluting microspheres in a salvage patient population. Cardiovasc Interv Radiol. 2014;37(1):154–64.

    Article  Google Scholar 

  3. Narayanan G, Barbery K, Suthar R, et al. Transarterial chemoembolization using DEBIRI for treatment of hepatic metastases from colorectal cancer. Anticancer Res. 2013;33(5):2077–83.

    CAS  PubMed  Google Scholar 

  4. Miyayama S, Matsui O, Taki K, et al. Extrahepatic blood supply to hepatocellular carcinoma: angiographic demonstration and transcatheter arterial chemoembolization. Cardiovasc Interv Radiol. 2006;29(1):39–48.

    Article  Google Scholar 

  5. Guiu B, Deschamps F, Aho S, et al. Liver/biliary injuries following chemoembolisation of endocrine tumours and hepatocellular carcinoma: lipiodol vs. drug-eluting beads. J Hepatol. 2012;56(3):609–17.

    Article  CAS  PubMed  Google Scholar 

  6. Ebert M, Ebert J, Berger G. Intravital microscopic research of microembolization with degradable starch microspheres. J Drug Deliv. 2013;2013:242060.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Nishiofuku H, Tanaka T, Matsuoka M, et al. Transcatheter arterial chemoembolization using cisplatin powder mixed with degradable starch microspheres for colorectal liver metastases after FOLFOX failure: results of a phase I/II study. J Vasc Interv Radiol. 2013;24(1):56–65.

    Article  PubMed  Google Scholar 

  8. Akahori T, Sho M, Tanaka T, et al. Significant efficacy of new transcatheter arterial chemoembolization technique for hepatic metastases of pancreatic neuroendocrine tumors. Anticancer Res. 2013;33(8):3355–8.

    PubMed  Google Scholar 

  9. Takada K, Kawamura T, Inai M, et al. Pharmacokinetics of cisplatin in analbuminemic rats. Biopharm Drug Dispos. 1999;20(9):421–8.

    Article  CAS  PubMed  Google Scholar 

  10. Yoshikawa M, Ono N, Yodono H, et al. Phase II study of hepatic arterial infusion of a fine-powder formulation of cisplatin for advanced hepatocellular carcinoma. Hepatol Res. 2008;38(5):474–83.

    Article  CAS  PubMed  Google Scholar 

  11. Shen DW, Akiyama S, Schoenlein P, et al. Characterisation of high-level cisplatin-resistant cell lines established from a human hepatoma cell line and human KB adenocarcinoma cells: cross-resistance and protein changes. Br J Cancer. 1995;71(4):676–83.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Ono Y, Yoshimasu T, Ashikaga R, et al. Long-term results of lipiodol-transcatheter arterial embolization with cisplatin or doxorubicin for unresectable hepatocellular carcinoma. Am J Clin Oncol. 2000;23(6):564–8.

    Article  CAS  PubMed  Google Scholar 

  13. Maeda N, Osuga K, Shimazu K, et al. In vivo evaluation of cisplatin-loaded superabsorbent polymer microspheres for use in chemoembolization of VX2 liver tumors. J Vasc Interv Radiol. 2012;23(3):397–404.

    Article  PubMed  Google Scholar 

  14. Pieper CC, Meyer C, Vollmar B, et al. Temporary arterial embolization of liver parenchyma with degradable starch microspheres (EmboCept®S) in a swine model. Cardiovasc Interv Radiol. 2015;38(2):435–41.

    Article  Google Scholar 

  15. Tanaka T, Nishiofuku H, Maeda S, et al. Repeated bland-TAE using small microspheres injected via an implantable port-catheter system for liver metastases: an initial experience. Cardiovasc Interv Radiol. 2014;37(2):493–7.

    Article  Google Scholar 

  16. Erinjeri JP, Salhab HM, Covey AM, et al. Arterial patency after repeated hepatic artery bland particle embolization. J Vasc Interv Radiol. 2010;21(4):522–6.

    Article  PubMed  Google Scholar 

  17. Rao PP, Pascale F, Seck A, et al. Irinotecan loaded in eluting beads: preclinical assessment in a rabbit VX2 liver tumor model. Cardiovasc Interv Radiol. 2012;35(6):1448–59.

    Article  Google Scholar 

  18. Ramirez LH, Munck JN, Bognel C, et al. Pharmacology and antitumour effects of intraportal pirarubicin on experimental liver metastases. Br J Cancer. 1993;68(2):277–81.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Sadahiro S, Suzuki T, Ishikawa K. Pharmacokinetics of 5-fluorouracil following hepatic intra-arterial infusion in a VX2 hepatic metastasis model. Jpn J Clin Oncol. 2003;33(8):377–81.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

We thank Ms. Marian Pahud for advice in submitting this article. This work was partially supported by Grant-in-Aid for Scientific Research (C), 26461868, and Nara Medical University Grant-in-Aid for Collaborative Research Projects.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Toshihiro Tanaka.

Ethics declarations

Conflict of interest

All authors have no conflicts of interest and financial disclosures to declare.

Research Involving Animal and Human Rights

All applicable institutional and/or national guidelines for the care and use of animals were followed.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sato, T., Tanaka, T., Nishiofuku, H. et al. Pharmacokinetics and Histopathological Findings of Chemoembolization Using Cisplatin Powder Mixed with Degradable Starch Microspheres in a Rabbit Liver Tumor Model. Cardiovasc Intervent Radiol 40, 438–444 (2017). https://doi.org/10.1007/s00270-016-1512-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00270-016-1512-1

Keywords

Navigation